Captrust Financial Advisors Moderna, Inc. Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Moderna, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 4,387 shares of MRNA stock, worth $176,664. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,387

Previous 8,442 48.03%

Holding current value

$176,664

Previous $1 Million 70.76%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $258,060 - $507,442	-4,055 Reduced 48.03%	4,387 $293,000
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $4,048 - $6,664	-40 Reduced 0.47%	8,442 $1 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $375,115 - $507,243	-4,394 Reduced 34.13%	8,482 $903,000
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $41,636 - $62,553	-599 Reduced 4.45%	12,876 $1.28 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $95,060 - $124,837	986 Added 7.89%	13,475 $1.39 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $123,358 - $167,111	-1,041 Reduced 7.69%	12,489 $1.52 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $597,039 - $867,085	-4,401 Reduced 24.54%	13,530 $2.08 Million
Q4 2022 Feb 15, 2023	BUY	$118.38 - $210.04 $335,015 - $594,413	2,830 Added 18.74%	17,931 $3.22 Million
Q3 2022 Nov 16, 2022	BUY	$118.07 - $194.18 $490,935 - $807,400	4,158 Added 38.0%	15,101 $1.79 Million
Q2 2022 Aug 23, 2022	SELL	$117.13 - $176.59 $36,076 - $54,389	-308 Reduced 2.74%	10,943 $1.56 Million
Q2 2022 Aug 16, 2022	BUY	$117.13 - $176.59 $349,633 - $527,121	2,985 Added 36.11%	11,251 $1.61 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $53,998 - $100,366	-427 Reduced 4.91%	8,266 $1.42 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $1.25 Million - $2.03 Million	-5,515 Reduced 38.82%	8,693 $2.21 Million
Q3 2021 Nov 16, 2021	BUY	$221.9 - $484.47 $185,730 - $405,501	837 Added 6.26%	14,208 $5.47 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $416,491 - $753,345	3,206 Added 31.54%	13,371 $3.14 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $127,522 - $217,224	1,168 Added 12.98%	10,165 $1.33 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $197,548 - $510,429	3,005 Added 50.15%	8,997 $940,000
Q3 2020 Nov 17, 2020	SELL	$54.34 - $94.85 $616,432 - $1.08 Million	-11,344 Reduced 65.44%	5,992 $420,000
Q2 2020 Aug 14, 2020	SELL	$29.67 - $80.0 $127,135 - $342,800	-4,285 Reduced 19.82%	17,336 $1.07 Million
Q1 2020 May 15, 2020	SELL	$17.78 - $31.58 $4,836 - $8,589	-272 Reduced 1.24%	21,621 $641,000
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $304,969 - $465,883	21,893 New	21,893 $421,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Moderna, Inc. Transaction History